Verastem Inc (NASDAQ:VSTM)
| 9.29 Data as of May 24 |  +0.03 / +0.32%Today’s Change | 6.25 Today|||52-Week Range 12.00 | +5.69% Year-to-Date |
Latest VSTM News | Press Releases
No recent news for Verastem Inc.
Today’s Trading
| Previous close | 9.26 |
| Today’s open | 9.25 |
| Day’s range | 9.00 - 9.46 |
| Volume | 34,525 |
| Average volume (3 months) | 20,516 |
| Market cap | $197.8M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | +83.95% |
| Earnings growth (this year) | +1.26% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.09 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CGENCompugen Ltd | -0.04 | -0.74% |
| SIGASIGA Technologies In... | +0.06 | +1.67% |
| OVASOvaScience Inc | +0.10 | +0.87% |
| PSTIPluristem Therapeuti... | -0.03 | -0.98% |
Data as of 4:00pm ET, 05/24/2013
Financials
| Next reporting date | August 12, 2013 |
| EPS forecast (this quarter) | -$0.39 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$32.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Christoph H. Westphal, MD, PhD |
President & Chief Operating Officer Robert M. Forrester |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
